11/25/2025
In the early stages of gut–immune imbalance, subtle shifts can be easy to miss. LPS IgA captures those early signals and helps ground your clinical decision-making.
Because it reflects how the immune system is responding at the gut barrier, it often helps contextualize cases where timing, triggers, and symptom clusters feel unclear. Instead of guessing whether the gut is contributing, LPS IgA adds a measurable signal you can actually work with.
If you’re mapping early immune stress, tracking barrier integrity, or evaluating complex cases with overlapping complaints, this marker gives you meaningful direction—especially when paired with other gut and food immune insights in Array 2–based combos.